Emgrast 300mcg Injection
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Filgrastim (300mcg)
Overview Emgrast 300mcg Injection
Filgrastim 300mcg injection combats infection risk following chemotherapy. This growth factor boosts white blood cell production in the bone marrow, bolstering the body's infection defenses. Administration is via injection by a healthcare professional, continuing as directed. Treatment length depends on individual response. Regular blood counts and bone density monitoring may be required. Common side effects include bone pain, fatigue, headache, and skin rash; injection site pain or redness is also typical. Report persistent lumps, swelling, or bruising. While it doesn't guarantee complete infection prevention, fever, chills, rash, sore throat, or facial/neck swelling warrant immediate medical attention. Inform your doctor of all other medications, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is crucial throughout treatment.
Uses of Emgrast 300mcg Injection
Protecting against infection following chemotherapy
Major Benefits of Emgrast 300mcg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emgrast 300mcg Injection:
- Bone pain
- Weakness
- Headache
- Rash
- Nausea
- Increased lactate dehydrogenase level in blood
- Vomiting
- Increased uric acid level in blood
- Oropharyngeal pain
- Hair loss
- Fatigue
- Diarrhea
- Constipation
- Decreased appetite
- Cough
- Breathing problems
- Injection site reactions (pain, swelling, redness)
How to use Emgrast 300mcg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Emgrast 300mcg Injection works:
Filgrastim 300mcg injection promotes white blood cell production in the bone marrow, bolstering the body's infection-fighting defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Emgrast 300mcg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Emgrast 300mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The administration of Emgrast 300mcg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Emgrast 300mcg Injection may induce adverse reactions, potentially impairing driving capabilities. Emgrast 300mcg Injection can lead to tiredness, which might compromise safe driving.
KidneySAFE IF PRESCRIBED
Emgrast 300mcg Injection poses no safety concerns for individuals with renal impairment, and no alteration of the prescribed dosage is necessary.
LiverSAFE IF PRESCRIBED
The 300 mcg Emgrast injection presents no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Emgrast 300mcg Injection :
Should you inadvertently skip a dose of the Emgrast 300mcg injection, seek advice from your physician.
Facts to Know About Emgrast 300mcg Injection
| Label | Value |
|---|---|
| Chemical Type | Granulocyte colony-stimulating factor |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | G-CSF (granulocyte colony-stimulating factor) |
3,018 People bought this recently